These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
242 related articles for article (PubMed ID: 35638225)
1. The relationship between metabolic syndrome and its components with bladder cancer: a systematic review and meta-analysis of cohort studies. Ahmadinezhad M; Arshadi M; Hesari E; Sharafoddin M; Azizi H; Khodamoradi F Epidemiol Health; 2022; 44():e2022050. PubMed ID: 35638225 [TBL] [Abstract][Full Text] [Related]
2. The association between metabolic syndrome and bladder cancer susceptibility and prognosis: an updated comprehensive evidence synthesis of 95 observational studies involving 97,795,299 subjects. Peng XF; Meng XY; Wei C; Xing ZH; Huang JB; Fang ZF; Hu XQ; Liu QM; Zhu ZW; Zhou SH Cancer Manag Res; 2018; 10():6263-6274. PubMed ID: 30568489 [TBL] [Abstract][Full Text] [Related]
3. Association of obesity and other anthropometric characteristics with bladder cancer risk: a systematic review and meta-analysis of longitudinal cohort studies. Tzelves L; Xenou D; Skolarikos A; Varkarakis I; Deliveliotis C; Terpos E; Stamatelopoulos K; Sergentanis TN; Psaltopoulou T J BUON; 2021; 26(3):1040-1055. PubMed ID: 34268971 [TBL] [Abstract][Full Text] [Related]
4. Age of menarche and primary bladder cancer risk: A meta-analysis and systematic review. Li YD; Gao L; Gou YQ; Tan W; Liu C Urol Oncol; 2022 Jul; 40(7):346.e17-346.e26. PubMed ID: 35400567 [TBL] [Abstract][Full Text] [Related]
5. Pulmonary Function in Metabolic Syndrome: A Meta-Analysis. Fang NN; Wang ZH; Li SH; Ge YY; Liu X; Sui DX Metab Syndr Relat Disord; 2022 Dec; 20(10):606-617. PubMed ID: 36125502 [No Abstract] [Full Text] [Related]
6. Antihypertensive medications are associated with the risk of kidney and bladder cancer: a systematic review and meta-analysis. Xie Y; Xu P; Wang M; Zheng Y; Tian T; Yang S; Deng Y; Wu Y; Zhai Z; Hao Q; Song D; Zhang D; Dai Z Aging (Albany NY); 2020 Jan; 12(2):1545-1562. PubMed ID: 31968309 [TBL] [Abstract][Full Text] [Related]
7. Benign Prostatic Hyperplasia and the Risk of Prostate Cancer and Bladder Cancer: A Meta-Analysis of Observational Studies. Dai X; Fang X; Ma Y; Xianyu J Medicine (Baltimore); 2016 May; 95(18):e3493. PubMed ID: 27149447 [TBL] [Abstract][Full Text] [Related]
8. Obesity and risk of bladder cancer: a meta-analysis of cohort studies. Qin Q; Xu X; Wang X; Zheng XY Asian Pac J Cancer Prev; 2013; 14(5):3117-21. PubMed ID: 23803089 [TBL] [Abstract][Full Text] [Related]
9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
10. Risk of bladder cancer in patients with diabetes mellitus: an updated meta-analysis of 36 observational studies. Zhu Z; Wang X; Shen Z; Lu Y; Zhong S; Xu C BMC Cancer; 2013 Jun; 13():310. PubMed ID: 23803148 [TBL] [Abstract][Full Text] [Related]
11. Obesity and risk of bladder cancer: a dose-response meta-analysis of 15 cohort studies. Sun JW; Zhao LG; Yang Y; Ma X; Wang YY; Xiang YB PLoS One; 2015; 10(3):e0119313. PubMed ID: 25803438 [TBL] [Abstract][Full Text] [Related]
12. Diabetes mellitus and risk of bladder cancer: a meta-analysis of cohort studies. Xu X; Wu J; Mao Y; Zhu Y; Hu Z; Xu X; Lin Y; Chen H; Zheng X; Qin J; Xie L PLoS One; 2013; 8(3):e58079. PubMed ID: 23472134 [TBL] [Abstract][Full Text] [Related]
13. Association between metabolic syndrome and myocardial infarction among patients with excess body weight: a systematic review and meta-analysis. Sedaghat Z; Khodakarim S; Nejadghaderi SA; Sabour S BMC Public Health; 2024 Feb; 24(1):444. PubMed ID: 38347488 [TBL] [Abstract][Full Text] [Related]
14. Diabetes mellitus increases the risk of bladder cancer: an updated meta-analysis of observational studies. Fang H; Yao B; Yan Y; Xu H; Liu Y; Tang H; Zhou J; Cao L; Wang W; Zhang J; Zhao L; Chen X; Zhang F; Zhao Y Diabetes Technol Ther; 2013 Nov; 15(11):914-22. PubMed ID: 24180357 [TBL] [Abstract][Full Text] [Related]
15. The association between physical activity and bladder cancer: systematic review and meta-analysis. Keimling M; Behrens G; Schmid D; Jochem C; Leitzmann MF Br J Cancer; 2014 Apr; 110(7):1862-70. PubMed ID: 24594995 [TBL] [Abstract][Full Text] [Related]
16. Association between metabolic syndrome, obesity, diabetes mellitus and oncological outcomes of bladder cancer: a systematic review. Cantiello F; Cicione A; Salonia A; Autorino R; De Nunzio C; Briganti A; Gandaglia G; Dell'Oglio P; Capogrosso P; Damiano R Int J Urol; 2015 Jan; 22(1):22-32. PubMed ID: 25345683 [TBL] [Abstract][Full Text] [Related]
17. Association Between Anthropometric Risk Factors and Metabolic Syndrome Among Adults in India: A Systematic Review and Meta-Analysis of Observational Studies. Krishnamoorthy Y; Rajaa S; Murali S; Sahoo J; Kar SS Prev Chronic Dis; 2022 May; 19():E24. PubMed ID: 35512304 [TBL] [Abstract][Full Text] [Related]
18. Diabetes mellitus and risk of bladder cancer: a meta-analysis. Larsson SC; Orsini N; Brismar K; Wolk A Diabetologia; 2006 Dec; 49(12):2819-23. PubMed ID: 17021919 [TBL] [Abstract][Full Text] [Related]
19. The Metabolic Syndrome Is a Risk Factor for Breast Cancer: A Systematic Review and Meta-Analysis. Zhao P; Xia N; Zhang H; Deng T Obes Facts; 2020; 13(4):384-396. PubMed ID: 32698183 [TBL] [Abstract][Full Text] [Related]